Fudan University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
The Effect of Chronic Anemia on Safety Period of Tracheal Intubation in Gynecology Patients
Not Applicable
Completed
- Conditions
- Chronic Anemia
- Interventions
- Biological: pre-oxygen
- First Posted Date
- 2013-10-24
- Last Posted Date
- 2013-10-24
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 45
- Registration Number
- NCT01968525
- Locations
- 🇨🇳
Fudan university, Shanghai, Shanghai, China
A Phase II Trial of Exploring the Predictive Factors of TX and XELOX Regimen in the First Line Treatment of MGC
- First Posted Date
- 2013-10-16
- Last Posted Date
- 2013-10-16
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 120
- Registration Number
- NCT01963702
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery
- First Posted Date
- 2013-09-06
- Last Posted Date
- 2019-08-05
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 112
- Registration Number
- NCT01936233
- Locations
- 🇨🇳
Liver Cancer Institute, Shanghai, Shanghai, China
Capecitabine Metronomic Chemotherapy Plus Aromatase Inhibitor for Postmenopausal Hormone Receptor Positive Breast Cancer
- First Posted Date
- 2013-08-16
- Last Posted Date
- 2013-08-16
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 100
- Registration Number
- NCT01924078
- Locations
- 🇨🇳
FUSCC, Shanghai, Shanghai, China
Dose-adjusted EPOCH-R in MYC Positive DLBCL
Phase 2
Terminated
- Conditions
- Diffuse Large B-cell Lymphoma
- Interventions
- Drug: DA-EPOCH-R
- First Posted Date
- 2013-08-02
- Last Posted Date
- 2014-08-20
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 26
- Registration Number
- NCT01914718
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
Entecavir Versus Lamivudine for Preventing the Risk of Hepatitis B Reactivation in NHL
Phase 2
- Conditions
- Non-Hodgkin LymphomaHepatitis B Reactivation
- Interventions
- First Posted Date
- 2013-08-02
- Last Posted Date
- 2013-08-02
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 82
- Registration Number
- NCT01914744
- Locations
- 🇨🇳
Fudan University Cancer Hospital, Shanghai, Shanghai, China
Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE
Phase 2
- Conditions
- VomitingNauseaMetastatic Liver Cancer
- Interventions
- Device: acupoint electric stimulation
- First Posted Date
- 2013-07-10
- Last Posted Date
- 2013-07-10
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 74
- Registration Number
- NCT01895010
- Locations
- 🇨🇳
Shanghai Cancer Center, Shanghai, Shanghai, China
Treatment of Cerebral Radiation Necrosis With GM1, a Prospective Study
- Conditions
- RadiotherapyNasopharyngeal CarcinomaCerebral Radiation NecrosisMRI
- Interventions
- First Posted Date
- 2013-06-24
- Last Posted Date
- 2014-01-07
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 30
- Registration Number
- NCT01884987
- Locations
- 🇨🇳
Shanghai Cancer Center, Fudan University, Shanghai, China
Acupuncture Research on Lung Cancer Patients With Cancer Related Fatigue（CRF）
Phase 2
- Conditions
- Lung CancerCancer Related Fatigue
- Interventions
- Device: acupunctureDevice: sham acupuncture
- First Posted Date
- 2013-06-19
- Last Posted Date
- 2013-06-19
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 32
- Registration Number
- NCT01881516
A Study of PC Sequential Pemetrexed Single Drug Maintenance Treatment for NSCLC and Related Predictive Biomarkers
- First Posted Date
- 2013-05-22
- Last Posted Date
- 2013-07-08
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 94
- Registration Number
- NCT01860508
- Locations
- 🇨🇳
Cancer hospital Fudan University, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath